secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0000950170-24-121064
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker Q3 revenue up 16.4% but GAAP EPS $0.27 down from $0.60; FY2024 guidance lowered
--------------------------------------------------------------------------------

- Q3 revenue $864.4M, up 16.4% YoY; organic growth 3.1%, CER growth 15.7%.
- GAAP EPS $0.27 vs $0.60 prior year; non-GAAP EPS $0.60 vs $0.74, down 18.9%.
- BSI segment organic revenue grew 3.8% YoY; BEST segment organic revenue declined 3.2%.
- FY2024 revenue guidance lowered to $3.34-$3.37B (organic growth 3-4%); non-GAAP EPS $2.36-$2.41.
- Management cites persistent biopharma and China headwinds as reason for guidance cut.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000095017024121064/0000950170-24-121064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000095017024121064/brkr-20241105.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-121064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer